Kidney Disease Clinical Trials in Chicago

Showing 361-380 of 484 trials

Crossover Study to Compare PK of Once Daily LCP-Tacro Tablets to Generic Tacrolimus Capsules Twice Daily.

NCT01962922

Open label, prospective, single-center, randomized, two sequence, three period crossover study to compare the steady state pharmacokinetics of LCP-Tacro tables to generic tacrolimus capsules administered twice daily in stable African-American renal transplant patients.

Renal Failure

Veloxis Pharmaceuticals50 participantsStarted Nov 2013

Chicago, Illinois, United States • St Louis, Missouri, United States • Philadelphia, Pennsylvania, United States

COMPLETEDPhase 22.2 miles

Exploratory Study Evaluating Fluorodeoxyglucose - Position Emission Tomography as a Predictive Marker for Therapy With RAD001 in Metastatic Renal Cell Cancer

NCT00529802

The purpose of this study is to learn if PET scanning can predict the degree of tumor shrinkage with the study drug RAD001 in subjects who have advanced renal cancer.

Carcinoma, Renal Cell

University of Chicago60 participantsStarted Sep 2007

Chicago, Illinois, United States • Peoria, Illinois, United States • Boston, Massachusetts, United States +2 more locations

COMPLETEDPhase 32.2 miles

Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1

NCT00089570

The purpose of this study is to determine whether terlipressin is safe and effective in the treatment of patients with hepatorenal syndrome (HRS) type 1 when compared to placebo.

Hepatorenal Syndrome

Mallinckrodt112 participantsStarted Jun 2004

Phoenix, Arizona, United States • Tucson, Arizona, United States • Los Angeles, California, United States +34 more locations

Crossover Study to Compare PK of Once Daily LCP-Tacro Tablets to Generic Tacrolimus Capsules Twice Daily.

Exploratory Study Evaluating Fluorodeoxyglucose - Position Emission Tomography as a Predictive Marker for Therapy With RAD001 in Metastatic Renal Cell Cancer

Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1

Kidney Disease Trials in Other Cities

Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)

Exercise in Obese Diabetic Patients With Chronic Kidney Disease

A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis

Pazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma

A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)

Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Continued Access Study

The Vascutek AnacondaTM Stent Graft System Phase II IDE Study

Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma

VEG111485: A QTc Study of Pazopanib

A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT

Study Of Palbociclib (PD-0332991) In Renal Impairment

Effects of PINTA 745 in End Stage Renal Disease (ESRD) Patients Who Require Hemodialysis and Have Protein Energy Wasting

Part A: Radiolabel Study With GW786034 Part B: Single Dose of GW786034

A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor (TKI) - Failure in Patients With Renal Cancer

A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors

Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD

Other Conditions in Chicago